Diseases, Conditions, Syndromes

COVID-19 hot spots offer sign of what could be ahead for US

The contagious delta variant is driving up COVID-19 hospitalizations in the Mountain West and fueling disruptive outbreaks in the North, a worrisome sign of what could be ahead this winter in the U.S.

Vaccination

Covaxin approval requested in US for ages 2-18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

Pediatrics

Caution urged before vaccinating kids under 12 against COVID-19

Any decision to vaccinate all children under 12 years of age against COVID-19 must be done with due caution, considering in detail the risk and benefits, according to a new review by international pediatric vaccine experts.

Vaccination

COVID-19 vaccine campaign expands to elementary-age children

The U.S. enters a new phase Wednesday in its COVID-19 vaccination campaign, with shots now available to millions of elementary-age children in what health officials hailed as a major breakthrough after more than 18 months ...

page 26 from 40